MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Recessive Dystrophic Epidermolysis Bullosa

  1. Home
  2. Diseases
  3. Recessive Dystrophic Epidermolysis Bullosa
  4. Clinical Trials

Clinical Trials Related to Recessive Dystrophic Epidermolysis Bullosa

Related studies linked through entity extraction aliases.

NCT03012191

Gentamicin for RDEB

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT02984085

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Status
TERMINATED
Phase
PHASE1/PHASE2

NCT02698735

Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT02493816

Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa

Status
COMPLETED
Phase
PHASE1

NCT02323789

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Status
UNKNOWN
Phase
PHASE1/PHASE2

NCT01874769

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Status
COMPLETED
Phase
N/A
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.